PARIS (Agefi-Dow Jones)--Le laboratoire pharmaceutique Sanofi a annoncé jeudi que le Comité des médicaments à usage humain ...
(AOF) - Amundi Amundi a annoncé l'acquisition d'aixigo, société technologique ayant développé une offre de services modulaire pour les ...
Bonne nouvelle pour le quartier d'affaires. A l'été 2027, au moins 2.700 des 3.700 salariés du site de Gentilly devraient ...
A major news story from Sanofi this month is that "The European Medicines Agency has approved Dupixent (dupilumab) to treat ...
Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...
Sanofi a installé à Paris un « accélérateur digital » afin d'intégrer l’intelligence artificielle aux logiciels de recherche.
Today, Formation Bio, together with OpenAI and Sanofi, introduced Muse, an advanced AI-powered tool developed to accelerate and improve drug development by optimizing patient recruitment for clinical ...
Paris: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic ...
French drugmaker Sanofi has revealed the results from the Phase III LUNA 3 trial of rilzabrutinib, an oral bruton tyrosine kinase (BTK) inhibitor, in persistent or chronic immune thrombocytopenia (ITP ...
PARIS (Agefi-Dow Jones)--Le laboratoire pharmaceutique Sanofi a annoncé mercredi que l'Agence européenne des médicaments ...
(Boursier.com) — Clotilde DELBOS, Administrateur de SANOFI, a acquis 500 actions le 31 octobre 2024, au prix unitaire de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback